FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and medicine and deals with composition for parenteral introduction, which contains (wt %): 2-ethyl-6-methyl-3-hydroxypyridine succinate as active component - 4.0-6.0; stabiliser - sodium metabisulfite - 0.015-0.045 and water as solvent - to 100. Claimed invention also relates to method of obtaining said composition. Composition is characterised by stability during three years, low toxicity, comparable with 2-ethyl-6-methyl-3-hydroxypyridine succinate solution without stabilisers, makes it possible to realise therapeutic action of active substance without undesirable side pharmacologic activity of auxiliary substances.
EFFECT: invention can be used in medicine as medication for treatment and prevention of various diseases and pathological states of human organism.
3 cl, 6 ex, 2 tbl
